IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine Regimens

RV144 correlates of risk analysis showed that IgG antibodies to gp70V1V2 scaffolds inversely correlated with risk of HIV acquisition. We investigated IgG antibody responses in RV135 and RV132, two ALVAC-HIV prime-boost vaccine trials conducted in Thailand prior to RV144. Both trials used ALVAC-HIV (...

Descripción completa

Detalles Bibliográficos
Autores principales: Karasavvas, Nicos, Karnasuta, Chitraporn, Savadsuk, Hathairat, Madnote, Sirinan, Inthawong, Dutsadee, Chantakulkij, Somsak, Rittiroongrad, Surawach, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Thongcharoen, Prasert, Siriyanon, Vinai, Andrews, Charla A., Barnett, Susan W., Tartaglia, James, Sinangil, Faruk, Francis, Donald P., Robb, Merlin L., Michael, Nelson L., Ngauy, Viseth, de Souza, Mark S., Paris, Robert M., Excler, Jean-Louis, Kim, Jerome H., O'Connell, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651018/
https://www.ncbi.nlm.nih.gov/pubmed/26234467
http://dx.doi.org/10.1089/aid.2015.0034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651018/
https://www.ncbi.nlm.nih.gov/pubmed/26234467
http://dx.doi.org/10.1089/aid.2015.0034

Ejemplares similares